Daniel M Hartung

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. ncbi request reprint Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population
    Daniel M Hartung
    Oregon State University College of Pharmacy, Portland, USA
    Clin Ther 26:1518-32. 2004
  2. pmc A pilot study evaluating alternative approaches of academic detailing in rural family practice clinics
    Daniel M Hartung
    Oregon State University College of Pharmacy, Oregon Health and Science University, Portland, OR, 97239, USA
    BMC Fam Pract 13:129. 2012
  3. pmc Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study
    Daniel M Hartung
    Oregon State University College of Pharmacy, Oregon Health and Science University, Portland, OR 97239, USA
    CNS Drugs 26:707-16. 2012
  4. pmc Effect of drug sample removal on prescribing in a family practice clinic
    Daniel M Hartung
    Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon, USA
    Ann Fam Med 8:402-9. 2010
  5. doi request reprint Overview of clinical research design
    Daniel M Hartung
    College of Pharmacy, Oregon State University, Portland, OR 97239, USA
    Am J Health Syst Pharm 66:398-408. 2009
  6. doi request reprint Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population
    Daniel M Hartung
    Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon 97239 4501, USA
    Med Care 46:565-72. 2008
  7. ncbi request reprint Rates of adverse events of long-acting opioids in a state Medicaid program
    Daniel M Hartung
    College of Pharmacy, Oregon State University, Oregon Health and Science University Campus, Portland, OR 97239, USA
    Ann Pharmacother 41:921-8. 2007
  8. ncbi request reprint Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program
    Ann M Hamer
    Drug Use Research and Mangement Program, Oregon State University College of Pharmacy, Portland, OR 97201 4952, USA
    J Manag Care Pharm 12:449-56. 2006
  9. pmc Patterns of atypical antipsychotic subtherapeutic dosing among Oregon Medicaid patients
    Daniel M Hartung
    Oregon State University, Portland, USA
    J Clin Psychiatry 69:1540-7. 2008
  10. ncbi request reprint Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study
    Daniel M Hartung
    College of Pharmacy, Oregon State University, Portland, Oregon, USA
    Pharmacotherapy 25:1329-36. 2005

Detail Information

Publications14

  1. ncbi request reprint Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population
    Daniel M Hartung
    Oregon State University College of Pharmacy, Portland, USA
    Clin Ther 26:1518-32. 2004
    ..Prior authorization (PA) is a poorly studied but commonly employed policy used by health care payers to manage the rising costs of pharmacy benefits...
  2. pmc A pilot study evaluating alternative approaches of academic detailing in rural family practice clinics
    Daniel M Hartung
    Oregon State University College of Pharmacy, Oregon Health and Science University, Portland, OR, 97239, USA
    BMC Fam Pract 13:129. 2012
    ..Our study evaluates different models of delivering academic detailing in a rural family medicine setting...
  3. pmc Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study
    Daniel M Hartung
    Oregon State University College of Pharmacy, Oregon Health and Science University, Portland, OR 97239, USA
    CNS Drugs 26:707-16. 2012
    ..Lamotrigine, the prototypical newer AED, is often used for psychiatric and neurological conditions other than epilepsy. The safety of generic substitution of lamotrigine in diverse populations of AED users is unclear...
  4. pmc Effect of drug sample removal on prescribing in a family practice clinic
    Daniel M Hartung
    Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon, USA
    Ann Fam Med 8:402-9. 2010
    ..The objective of this study was to evaluate the effect of a policy prohibiting prescription drug samples and pharmaceutical industry interaction on prescribing patterns in a rural family practice clinic in central Oregon...
  5. doi request reprint Overview of clinical research design
    Daniel M Hartung
    College of Pharmacy, Oregon State University, Portland, OR 97239, USA
    Am J Health Syst Pharm 66:398-408. 2009
    ..Basic concepts and terminology of clinical research design are presented for new clinical investigators...
  6. doi request reprint Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population
    Daniel M Hartung
    Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon 97239 4501, USA
    Med Care 46:565-72. 2008
    ..Research exploring the effects of copays on pharmacy and health care utilization in Medicaid patients is limited, especially among patients with chronic disease...
  7. ncbi request reprint Rates of adverse events of long-acting opioids in a state Medicaid program
    Daniel M Hartung
    College of Pharmacy, Oregon State University, Oregon Health and Science University Campus, Portland, OR 97239, USA
    Ann Pharmacother 41:921-8. 2007
    ..Despite widespread use and emerging safety concerns, data on the comparative safety and effectiveness of long-acting opioid (LAO) analgesics are weak...
  8. ncbi request reprint Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program
    Ann M Hamer
    Drug Use Research and Mangement Program, Oregon State University College of Pharmacy, Portland, OR 97201 4952, USA
    J Manag Care Pharm 12:449-56. 2006
    ..Dose form optimization can reduce the direct cost of therapy by up to 50% while continuing the same daily dose of the same drug molecule...
  9. pmc Patterns of atypical antipsychotic subtherapeutic dosing among Oregon Medicaid patients
    Daniel M Hartung
    Oregon State University, Portland, USA
    J Clin Psychiatry 69:1540-7. 2008
    ....
  10. ncbi request reprint Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study
    Daniel M Hartung
    College of Pharmacy, Oregon State University, Portland, Oregon, USA
    Pharmacotherapy 25:1329-36. 2005
    ..To determine, in patients with type 2 diabetes mellitus, whether an association exists between thiazolidinedione therapy or other diabetes therapies and hospital admission for heart failure...
  11. ncbi request reprint An evaluation of Oregon's evidence-based Practitioner-Managed Prescription Drug Plan
    Daniel M Hartung
    Drug Use Research and Management Program, College of Pharmacy, Oregon State University, Portland, USA
    Health Aff (Millwood) 25:1423-32. 2006
    ..1 percent and 17.7 percent after implementation of the DAW and soft PA policies, respectively. Data from nonenforced PMPDP classes showed no change; this suggests the need for effective methods to encourage PMPDP compliance...
  12. pmc Clinical implications of an accurate problem list on heart failure treatment
    Daniel M Hartung
    Oregon State University College of Pharmacy, Portland, OR, USA
    J Gen Intern Med 20:143-7. 2005
    ..However, little empirical evidence exists demonstrating improved patient outcomes as a result of an adequately structured problem list...
  13. doi request reprint Breaking up is hard to do: lessons learned from a pharma-free practice transformation
    David Evans
    Department of Family Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA
    J Am Board Fam Med 26:332-8. 2013
    ..Little guidance for practicing physicians exists about transforming practices to become pharma-free. Consideration must be given to the impact on practice culture, staff views, and patient needs...
  14. pmc Risk factors associated with linezolid-nonsusceptible enterococcal infections
    Jessina C McGregor
    College of Pharmacy, Oregon State University Oregon Health and Science University, Portland, OR 97239, USA
    Am J Infect Control 40:886-7. 2012
    ..Previous hospitalization, admission to a medical service, comorbidity, and linezolid and sulfonamide therapy were identified as risk factors...